Sonic Healthcare USA (SUSHA) announced it has acquired substantially all of the assets of Cairo Diagnostics, LLC, Cairo Diagnostics NJ, LLC and Rye Management and Logistics Corp. Cairo is a respected provider of comprehensive haematology oncology diagnostics based in White Plains, New York and with a second laboratory in Woodcliff Lake, New Jersey. With today's closing, SHUSA expects to integrate Cairo's medically led test menu and infrastructure into its national network, supported by SHUSA's logistics, payer contracting and commercial organisation.
Founded by hematopathologist Dr. Sherif Ibrahim in 2013, Cairo has been recognised for its integrated approach to oncology testing. Cairo Diagnostics provides personalised, comprehensive diagnostic reports by combining histopathology, molecular diagnostics, cytogenetics, flow cytometry, and immunohistochemistry under one roof. This approach is designed to reduce delays often encountered when testing is spread across multiple laboratories, supporting oncologists with more complete information to guide timely treatment decisions.
"This acquisition reflects Sonic's commitment to medical leadership in practice, not just in words," said Cory A. Roberts, MD, CEO of Sonic Healthcare USA, Inc. "By bringing Cairo's integrated oncology platforms into Sonic's network, we expect to access, service and support oncologists nationwide – expanding the reach of Cairo's expertise while strengthening SHUSA's capabilities in high-complexity oncology diagnostics."
"By combining Cairo's comprehensive menu with SHUSA's nationwide infrastructure, we can deliver faster, more complete answers to care teams," added Mohammed Salama, MD, Chief Medical Officer, Sonic Healthcare USA, Inc. "This acquisition positions us to expand into areas of innovation – including liquid biopsy and other emerging technologies—that will help anticipate the evolving needs of oncology care."
Dr. Ibrahim emphasised the shared focus on quality and scalability: "For over a decade, Cairo Diagnostics has focused on bringing essential tests together under one roof and delivering results in days, not weeks. Becoming part of Sonic Healthcare USA will allow that same quality and speed in oncology testing to reach providers and patients nationwide—while maintaining the responsive and personal approach that has defined us from the start. " Before founding Cairo, Dr. Ibrahim previously served in academic medicine at NYU, Memorial Sloan-Kettering, and MD Anderson Cancer Centre.
